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Background: Bovine leukemia virus (BLV) is highly endemic in many countries, including Argentina. As prevention
of the spread from infected animals is of primary importance in breaking the cycle of BLV transmission, it is important
to know the pathophysiology of BLV infection in young animals, as they are the main source of animal movement. In
this work, we determined the proviral load and antibody titers of infected newborn calves from birth to first parturition
(36 months).
Results: All calves under study were born to infected dams with high proviral load (PVL) in blood and high antibody
titers and detectable provirus in the colostrum. The PVL for five out of seven calves was low at birth. All animals
reached PVLs of more than 1% infected peripheral blood mononuclear cells (PBMCs), three at 3 months, one at
6 months, and one at 12 months. High PVLs persisted until the end of the study, and, in two animals, exceeded
one BLV copy per cell. Two other calves maintained a high PVL from birth until the end of the study. Antibody
titers were 32 or higher in the first sample from six out of seven calves. These decayed at 3–6 months to 16 or
lower, and then increased again after this point.
Conclusions: Calves infected during the first week of life could play an active role in early propagation of BLV to
susceptible animals, since their PVL raised up during the first 12 months and persist as high for years. Early elimination
could help to prevent transmission to young susceptible animals and to their own offspring. To our knowledge, this is
the first study of the kinetics of BLV proviral load and antibody titers in newborn infected calves.
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Bovine leukemia virus (BLV) is highly endemic in many
countries, including Argentina [1], where important
economic losses result from fatal lymphosarcoma and
restricted trade of genetic material. Because of the high
prevalence, classical control measures, such as test and
elimination and/or test and segregation, are not eco-
nomically sustainable. Therefore, infection transmission
should be decreased as much as practicable, to eventually
reduce prevalence and drive the infection to extinction.
A feasible alternative, previously discussed [1], could be
achieved by eliminating animals with high proviral loads
(PVLs), most of them with persistent lymphocytosis (PL)
[2,3], and as consequence, with a higher probability of
transmission of infection [4], when compared to aleukemic* Correspondence: ggutierrez@cnia.inta.gov.ar
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unless otherwise stated.(AL) animals. As prevention of spread from infected ani-
mals is of primary importance in breaking the cycle of BLV
transmission, it is important to know the pathophysiology
of BLV infection in young animals, as they are the main
source of animal movement. In this work, we followed the
PVL and antibody (Ab) titers of infected newborn calves
from birth to first parturition, to better understand
BLV infection evolution before calves enter the milking
herd, when cattle are commingled and infection is likely
to spread.
Results
Seven newborn infected calves were followed (Figure 1).
The PVLs of five out of seven calves were low at birth.
All animals reached PVL levels of more than 1% infected
peripheral blood mononuclear cells (PBMCs) (Figure 1);
three calves at 3 months, one calf at 6 months, and one
calf at 12 months. High PVLs persisted until the end of
the study (Figure 1). Calf #10902 maintained a high PVLal Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Kinetics of proviral load and antibody titers in new born infected calves. A cut-off value of 0.04 BLV copies/cell, corresponding to
1% BLV-infected PBMCs, is the threshold between low and high PVL according to our own criteria and published data.
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calf #10960 showed PVL fluctuations with a sporadic
decrease under the PVL threshold of 0.04 BLV copies/
cell at 3–6 months of age. The PVL of calves #10938
and #100 rose to more than 1 BLV copy/cell. Antibody
titers were 32 or higher in the first sample from all calves
except for calf #100 that showed the lowest antibody titer
at birth (8). Antibody titers decreased at 3–6 months to
16 or lower and then rose for the remainder of the
study. Six calves (#10902, #10934, #10938, #10960, #10964
and #10968) belonged to a dairy farm with a high BLV
prevalence; these represent 11% of the calves born in
the herd during 2 months. The dams of these calves had
high PVL in blood (6/6) (Table 1) and high antibody titers
(Figure 2) and detectable provirus (4/5) in the colostrum
(Table 1). Antibody levels detected in the calves’ blood
confirmed good colostrum intake and antibody absorp-
tion corresponding to highest antibody titers in the group
(Figure 2). Three animals could not be followed over
the 36 months; animal #10934 died at 18 months from
unrelated causes, #10960 was sold, and #100 was 2 years
old at the conclusion of this study.Table 1 Proviral load, antibody titers, and nested PCR
results from maternal blood and colostrum
Blood Colostrum
ID dam Id calf BLV copies/cell Nested PCR
1203 10964 0.4761 +
1278 10902 ND +
9442 10938 0.9392 -
10226 10968 0.3164 ND
26744 10934 0.4237 ND
26900 10960 0.1499 +
535 100 1.0870 +
ND: not determined, sample not available, +: positive, -: negative.Discussion
We followed the dynamics of BLV infection in calves that
acquired infection during the first week of life. While the
study size is limited, our data show that perinatal infection
can rapidly lead to PVLs similar to highly infected adult
cattle, and more than one copy of BLV provirus per cell
(Figure 1). Whether this is due to infection dose, animal
age, or the mechanism of transmission remains unclear
but suggests that newborn calves could become optimal
BLV propagators to neighboring cattle. While we cannot
confirm the infection source, the decay of antibodies at
3–6 months (Figure 1) suggests that infection was not
acquired in utero but by contact during delivery or viaFigure 2 Antibody titers in maternal colostrum and calves
plasma. Scatter plot showing the distribution of anti-BLV antibody titers
in 51 colostrum-calf paired samples belonging to the dairy farm where
all animals (except for calf #100) were born. Maternal colostrum and
calves antibody titers were significantly different (Mann Whitney,
P < 0.0001) and showed a positive correlation (Spearman rank test,
r = 0.638). Arrows indicate values of the calves under study.
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ported by the fact that all dams had high blood PVLs
and the majority had detectable provirus in colostrum
(Table 1), even in the presence of high antibody titers
(Figure 2). This finding is consonant with the data reported
for Human T-cell Lymphotropic Virus type-1 (HTLV-1), a
genetically and functionally related retrovirus, where high
PVLs in pregnant mothers are associated with a greater
probability of transmitting the infection to children during
delivery or by oral consumption of infected colostrum or
milk [5]. Whether the infection is prenatal or postnatal, the
rapid PVL rise suggests that the immune response does
not stop viral replication. This is supported by data that
show that while the calf immune system is functional at
birth, it is immature until at least 4 months of age [6].
Calves are immunosuppressed during the first week of life
because of estrogen and cortisol produced by the dam
before parturition and cortisol produced by the calf
during parturition [7]. Some cytokines that regulate BLV
expression and delay progression to PL in adult cattle,
including IFN-γ, IL-2, and IL-4 [8,9], are not efficiently
expressed during the first week of life. Moreover, reduced
levels of C3d (a subfragment of complement protein C3)
and the presence of maternal antibodies in serum may
result in the suppression of neonatal B lymphocytes, by
binding to their ligands CD21 (activation) and CD32
(supression), respectively [10]. Therefore, despite evidence
of adequate colostrum intake and absorption (Figures 1
and 2), the adaptive and innate immune responses were
not effective to maintain a balance between the response
and the viral infection cycle, and, as a consequence, did
not reach an equilibrium point within 3 to 8 months,
as recently reported for experimentally inoculated adult
sheep and cattle [11,12]. This is critical in terms of viral
transmission and infection epidemiology. We speculate
that viral burst cycles occur during the first few months
of life in perinatally infected calves, allowing rapid
transmission by contact to susceptible neighbors. Similar
observations have been made in HTLV-1 [13]. Moreover,
patients infected with HTLV-1 as children are more
prone to develop clinical signs [14]. While this was not
detected in this study, a similar phenomenon could occur
with BLV.
From an epidemiological point of view, the presence
of animals with high PVLs is dangerous. Because it is a
bloodborne pathogen, high levels of in vivo BLV infection
are associated with higher probability of transmission [4].
Because BLV is highly endemic in dairy herds, classical
control measures are not economically sustainable. Since
BLV infection produces serious economic losses due to
fatal lymphosarcoma and trade restrictions, alternative
programs must be developed to reduce the spread of
infection and gradually decrease infection prevalence.
Elimination of adult cattle with high PVLs, along withmovement of non-infected or low-infected heifers, may
prove to be a feasible alternative, as previously discussed
[1]. However, this approach requires uninfected heifers
for movement. This study suggests that young infected
animals represent a great risk for non-infected calves and
could be a reason for the increased incidence before first
parturition, when approximately half of pregnant heifers
are already infected, 20–40% with high PVLs [15]. Propa-
gation could occur through iatrogenic procedures or even
by contact with secretions or excretions that could be
infected with the virus. Moreover, virus could transfer
the maternal barrier when these animals are pregnant
spreading the infection to the offspring. A follow-up
large-scale study with perinatally infected calves would
be helpful to determine the prevalence of infection, range
of PVLs, monitor transmission, whether these animals are
more prone to develop lymphosarcoma, and to monitor
offspring and the related incidence of infection.Conclusion
Calves infected during the first week of life could play an
active role in early propagation of BLV to susceptible ani-
mals, since their PVL raised up during the first 12 months
and persist as high for years. Early elimination could help
to prevent transmission to young susceptible animals and
to their own offspring. To our knowledge, this is the first
study of the kinetics of BLV proviral load and antibody
titers in newborn infected calves.Methods
Animals
Study animals consisted of seven newborn calves with BLV
detected by nested PCR during the first week of life.
Six calves (#10902, #10934, #10938, #10960, #10964
and #10968) belonged to a typical dairy farm, with approxi-
mately 800 milking cows. Although this farm have used
corrective management practices to prevent spread of BLV
infection through iatrogenic procedures it had increasing
BLV prevalence with age: 11.4% at birth, 15% at 15 months,
40% at 27% months, 61.7% after first delivery, and 86.5% in
adult cows [16]. The remaining calf (#100) belonged to
an experimental farm in our facilities (CNIA – INTA)
with a BLV prevalence of 30%. Blood was taken by jugular
venipuncture with heparin. Plasma and whole blood was
stocked frozen until analyzed. Farm owners’ consent was
obtained before animal sampling. The procedures followed
for extraction and handling of samples were approved by
the Institutional Committee for Care and Use of Experi-
mental Animals of the National Institute of Agricultural
Technology (CICUAE-INTA) under protocol number 35/
2010 and followed the guidelines described in the institu-
tional Manual.
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Anti-BLV antibodies were detected in plasma and colos-
trum using an ELISA test developed in-house, as previously
reported [17]. Antibody titers were assayed by end-point
dilution using two-fold dilutions of plasma. Titers were
expressed as the reciprocal of the dilution.Proviral load detection and quantification
Total DNA was extracted from frozen whole blood or
whole colostrum using the High Pure PCR Template
Preparation kit (Roche, Penzberg, Germany) per the man-
ufacturer’s instructions. BLV proviral DNA was detected
by nested PCR [18] and quantified via real-time PCR [19]
using FastStart Universal SYBR Green Master (ROX)
(Roche). To determine proviral loads, a fragment of the
pol gene [19] was amplified using 50 ng of DNA as a
template. A standard curve was generated by amplification
of serial 10-fold dilutions of total DNA extracted from
fetal lamb kidney (FLK) cells containing four copies of
BLV proviral DNA per cell (from 50 to 0.005 ng of total
DNA corresponding to 85500 to 8.55 copies of the BLV
genome, respectively). The constitutive 18S ribosomal
gene was amplified in parallel as a reference [19]. Due
to the lack of an internationally harmonized threshold
to differentiate between low and high proviral load we
proposed and used DNA from FLK-BLV cells in a final
concentration of 1% in non-infected PBMCs as a threshold.
This cut-off point was stated using our own criteria and
based on published data [20] on the number of infected
cells in vivo in AL and PL animals, as PL animals have
more infected lymphocytes circulating, and thus, higher
proviral loads and higher probability of transmission of
infection [4]. The internal FLK 1% calibrator corresponds
to 0.04 BLV copies/cell in our system.
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